Comments
Biocon said that its wholly-owned subsidiary, Biocon Research Ltd, has entered into an agreement with GE Equity International Mauritius (a subsidiary of GE Capital), to purchase the latter’s stake in Biocon research services subsidiary, Syngene International, for Rs 215.38 crore.
GE Capital has 7.69 per cent stake in Syngene, Biocon said in a filing to the stock exchange.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.